Literature DB >> 20664912

A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues.

Noam Shomron1, Nobuko Hamasaki-Katagiri, Ryan Hunt, Klilah Hershko, Elie Pommier, S Geetha, Adam Blaisdell, Alexandra Dobkin, Andrew Marple, Isabella Roma, Jordan Newell, Courtni Allen, Scott Friedman, Chava Kimchi-Sarfaty.   

Abstract

Although ADAMTS13, the von Willebrand factor (VWF)-cleaving protease, is expressed in a range of tissues, the physiological significance of tissue-specific ADAMTS13 alternative splicing isoforms have yet to be clarified. Screening a panel of human tissues and cell lines revealed a spliced ADAMTS13 transcript in hepatic stellate cells and a hepatoma cell line that retains the 25th intron. A nonsense codon within the intron truncates the protease, which gains 64 novel amino acids in lieu of both CUB domains. This isoform, while retaining VWF-cleaving capability, accumulates intracellularly and its biological inaccessibility may prevent its participation in regulating haemostasis and other physiologic functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664912      PMCID: PMC2982681          DOI: 10.1160/TH09-12-0860

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers.

Authors:  Amir Goren; Oren Ram; Maayan Amit; Hadas Keren; Galit Lev-Maor; Ida Vig; Tal Pupko; Gil Ast
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

2.  Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.

Authors:  L Xu; A Y Hui; E Albanis; M J Arthur; S M O'Byrne; W S Blaner; P Mukherjee; S L Friedman; F J Eng
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura.

Authors:  X Zheng; D Chung; T K Takayama; E M Majerus; J E Sadler; K Fujikawa
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

4.  Binding of ADAMTS13 to von Willebrand factor.

Authors:  Elaine M Majerus; Patricia J Anderson; J Evan Sadler
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

5.  Localization of ADAMTS13 to the stellate cells of human liver.

Authors:  Masahito Uemura; Kouko Tatsumi; Masanori Matsumoto; Masao Fujimoto; Tomomi Matsuyama; Masatoshi Ishikawa; Taka-Aki Iwamoto; Toshio Mori; Akio Wanaka; Hiroshi Fukui; Yoshihiro Fujimura
Journal:  Blood       Date:  2005-04-26       Impact factor: 22.113

6.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13.

Authors:  John E Pimanda; Akiko Maekawa; Troels Wind; Julian Paxton; Colin N Chesterman; Philip J Hogg
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

8.  Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease.

Authors:  Fumiaki Banno; Kazuyoshi Kaminaka; Kenji Soejima; Koichi Kokame; Toshiyuki Miyata
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

9.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.

Authors:  Gene Yeo; Christopher B Burge
Journal:  J Comput Biol       Date:  2004       Impact factor: 1.479

Review 10.  Cancer and thrombosis.

Authors:  M B Donati
Journal:  Haemostasis       Date:  1994 Mar-Apr
View more
  6 in total

1.  ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2.

Authors:  Manfai Lee; Justin Keener; Juan Xiao; X Long Zheng; George M Rodgers
Journal:  Cell Mol Life Sci       Date:  2014-06-21       Impact factor: 9.261

2.  Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.

Authors:  Michael L Ekaney; Clemens L Bockmeyer; Maik Sossdorf; Philipp A Reuken; Florian Conradi; Tobias Schuerholz; Markus F Blaess; Scott L Friedman; Wolfgang Lösche; Michael Bauer; Ralf A Claus
Journal:  Mol Med       Date:  2015-04-03       Impact factor: 6.354

3.  Characterization of coding synonymous and non-synonymous variants in ADAMTS13 using ex vivo and in silico approaches.

Authors:  Nathan C Edwards; Zachary A Hing; Avital Perry; Adam Blaisdell; David B Kopelman; Robert Fathke; William Plum; Jordan Newell; Courtni E Allen; Geetha S; Aaron Shapiro; Chinyere Okunji; Idit Kosti; Noam Shomron; Vahan Grigoryan; Teresa M Przytycka; Zuben E Sauna; Raheleh Salari; Yael Mandel-Gutfreund; Anton A Komar; Chava Kimchi-Sarfaty
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

4.  DEIsoM: a hierarchical Bayesian model for identifying differentially expressed isoforms using biological replicates.

Authors:  Hao Peng; Yifan Yang; Shandian Zhe; Jian Wang; Michael Gribskov; Yuan Qi
Journal:  Bioinformatics       Date:  2017-10-01       Impact factor: 6.937

5.  Emerging Roles of ADAMTSs in Angiogenesis and Cancer.

Authors:  Saran Kumar; Nithya Rao; Ruowen Ge
Journal:  Cancers (Basel)       Date:  2012-11-29       Impact factor: 6.639

Review 6.  ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment.

Authors:  Nathalie Théret; Fidaa Bouezzedine; Fida Azar; Mona Diab-Assaf; Vincent Legagneux
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.